Table 1 Clinopathological characteristics of patients
Variable | MIS | Open | P-value |
|---|---|---|---|
|  | (n = 31) | (n = 68) |  |
Age, year, median (range) | 54(51,62) | 58(53,61) | 0.571 |
BMI, kg/m2,median (range) | 21.7(21.0,22.6) | 21.9(21.1,22.9) | 0.709 |
Comorbidity,% | Â | Â | 0.711 |
No | 14(45.2%) | 33(48.5%) | Â |
Yes | 17(54.8%) | 35(51.5%) | Â |
Histology,% | Â | Â | 0.116 |
Carcinosarcoma | 1(3.2%) | 6(8.8%) | Â |
Clear Cell | 8(25.8%) | 10(14.7%) | Â |
Serous | 9(29.0%) | 9(13.2%) | Â |
Mixed | 13(41.9%) | 38(55.9%) | Â |
Other | 0(0%) | 5(7.4%) | Â |
Endometrial thickness(TVUS), mm | Â | Â | 0.944 |
< 5 | 23(74.2%) | 50(73.5%) |  |
≥ 5 | 8(25.8%) | 18(26.5%) |  |
Different prognostic risks,% | Â | Â | 0.473 |
Intermediate -risk | 17(54.8%) | 32(47.1%) | Â |
High-risk | 14(45.2%) | 36(52.9%) | Â |
FIGO stage,% | Â | Â | 0.158 |
I-II | 26(83.9%) | 48(70.6%) | Â |
III-IVA | 5(16.1%) | 20(29.4%) | Â |
Type of hysterectomy,% | Â | Â | 0.811 |
RH | 27(87.1%) | 58(85.3%) | Â |
SH | 4(12.9%) | 10(14.7%) | Â |
Depth of myometrial invasion,% | Â | Â | 0.473 |
< 50% | 17(54.8%) | 32(47.1%) |  |
≤ 50% | 14(45.2%) | 36(52.9%) |  |
LN metastasis,% | Â | Â | 0.139 |
No | 28(90.3%) | 53(77.9%) | Â |
Yes | 3(9.7%) | 15(22.1%) | Â |
Tumor size,% | Â | Â | 0.283 |
< 5 | 18(58.1%) | 47(69.1%) |  |
≥ 5 | 13(41.9%) | 21(30.9%) |  |
LVSI positive,% | Â | Â | 0.126 |
No | 16(51.6%) | 46(67.6%) | Â |
Yes | 15(48.4%) | 22(32.4%) | Â |
Cervical stromal invasion,% | Â | Â | 0.607 |
No | 23(74.2%) | 47(69.1%) | Â |
Yes | 8(25.8%) | 21(30.9%) | Â |
Adjuvant therapy,% | Â | Â | 0.969 |
No | 9(29.0%) | 20(29.4%) | Â |
Yes | 22(71.0%) | 48(70.6%) | Â |
Recurrences,% | Â | Â | 0.007 |
No | 21(67.7%) | 61(89.7) | Â |
Yes | 10(32.3%) | 7(10.3%) | Â |
Survival state,% | Â | Â | 0.702 |
survival | 26(83.9%) | 59(86.8%) | Â |
death | 5(16.1%) | 9(13.2%) | Â |